MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma
- PMID: 26301891
- DOI: 10.1111/pcmr.12414
MITF is a critical regulator of the carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) in malignant melanoma
Abstract
The multifunctional Ig-like carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM1) is neo-expressed in the majority of malignant melanoma lesions. CEACAM1 acts as a driver of tumor cell invasion, and its expression correlates with poor patient prognosis. Despite its importance in melanoma progression, how CEACAM1 expression is regulated is largely unknown. Here, we show that CEACAM1 expression in melanoma cell lines and melanoma tissue strongly correlates with that of the microphthalmia-associated transcription factor (MITF), a key regulator of melanoma proliferation and invasiveness. MITF is revealed as a direct and positive regulator for CEACAM1 expression via binding to an M-box motif located in the CEACAM1 promoter. Taken together, our study provides novel insights into the regulation of CEACAM1 expression and suggests an MITF-CEACAM1 axis as a potential determinant of melanoma progression.
Keywords: M-box motif; carcinoembryonic antigen-related cell adhesion molecule 1; melanoma; microphthalmia-associated transcription factor.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Comment in
-
MITF and cell migration: opposing signals, similar outcome.Pigment Cell Melanoma Res. 2016 Mar;29(2):229-30. doi: 10.1111/pcmr.12439. Epub 2016 Jan 25. Pigment Cell Melanoma Res. 2016. PMID: 26575583 No abstract available.
Similar articles
-
CEACAM1: Expression and Role in Melanocyte Transformation.Dis Markers. 2016;2016:9406319. doi: 10.1155/2016/9406319. Epub 2016 Aug 24. Dis Markers. 2016. PMID: 27642217 Free PMC article. Review.
-
SOX9 indirectly regulates CEACAM1 expression and immune resistance in melanoma cells.Oncotarget. 2016 May 24;7(21):30166-77. doi: 10.18632/oncotarget.7379. Oncotarget. 2016. PMID: 26885752 Free PMC article.
-
A longitudinal study of CEACAM1 expression in melanoma disease progression.Oncol Rep. 2015 Mar;33(3):1314-8. doi: 10.3892/or.2014.3703. Epub 2014 Dec 30. Oncol Rep. 2015. PMID: 25573088
-
Tumor suppressor carcinoembryonic antigen-related cell adhesion molecule 1 potentates the anchorage-independent growth of human hepatoma HepG2 cells.Life Sci. 2007 Jul 4;81(4):336-45. doi: 10.1016/j.lfs.2007.06.002. Epub 2007 Jun 16. Life Sci. 2007. PMID: 17612570
-
[CEACAM1 as a central modulator of metabolism, tumor progression, angiogenesis and immunity].Med Sci (Paris). 2009 Mar;25(3):247-52. doi: 10.1051/medsci/2009253247. Med Sci (Paris). 2009. PMID: 19361387 Review. French.
Cited by
-
CEACAM1 Is a Prognostic Biomarker and Correlated with Immune Cell Infiltration in Clear Cell Renal Cell Carcinoma.Dis Markers. 2023 Jan 18;2023:3606362. doi: 10.1155/2023/3606362. eCollection 2023. Dis Markers. 2023. PMID: 36712923 Free PMC article.
-
Long non-coding RNA expression identified by microarray analysis: Candidate biomarkers in human acral lentiginous melanoma.Oncol Lett. 2020 Feb;19(2):1465-1477. doi: 10.3892/ol.2019.11207. Epub 2019 Dec 11. Oncol Lett. 2020. PMID: 31966073 Free PMC article.
-
CEACAM1: Expression and Role in Melanocyte Transformation.Dis Markers. 2016;2016:9406319. doi: 10.1155/2016/9406319. Epub 2016 Aug 24. Dis Markers. 2016. PMID: 27642217 Free PMC article. Review.
-
Cell Adhesion Molecules in Plasticity and Metastasis.Mol Cancer Res. 2021 Jan;19(1):25-37. doi: 10.1158/1541-7786.MCR-20-0595. Epub 2020 Oct 1. Mol Cancer Res. 2021. PMID: 33004622 Free PMC article. Review.
-
MITF and BRN2 contribute to metastatic growth after dissemination of melanoma.Sci Rep. 2017 Sep 7;7(1):10909. doi: 10.1038/s41598-017-11366-y. Sci Rep. 2017. PMID: 28883623 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous